$21.96
-0.19-0.86%
At Close: -
$21.96
00.00%
After Hours: 1:00 PM EDT
15 minutes delayed
Exelixis
EXELNASDAQ
Overview Rating
Speculative
Exelixis (NASDAQ:EXEL) Stock Quotes, Forecast and News Summary
Exelixis Stock (NASDAQ: EXEL) stock price, news, charts, stock research, profile.
| Open | $22.16 |
| Close | $21.96 |
| Volume / Avg. | 731.89K / 1.96M |
| Day Range | 21.82 - 22.22 |
| 52 Wk Range | 18.64 - 24.34 |
| Market Cap | $6.40B |
| P/E Ratio | 34.08 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 49 |
| Short Interest | 4.56% |
| Days to Cover | 7.2 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Exelixis Inc
Sector
Health Care
Industry
Biotechnology
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for can...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Exelixis (EXEL) stock?
You can purchase shares of Exelixis (NASDAQ:EXEL) through any online brokerage.
Who are Exelixis (EXEL) competitors?
Other companies in Exelixis’s space includes: Legend Biotech (NASDAQ:LEGN), Avidity Biosciences (NASDAQ:RNA), Exact Sciences (NASDAQ:EXAS), Ionis Pharmaceuticals (NASDAQ:IONS) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
What is the target price for Exelixis (EXEL) stock?
There is no analysis for Exelixis.
What is the forecast for Exelixis (EXEL) stock?
Exelixis has a consensus price target of $27.68.
Current stock price for Exelixis (EXEL)?
The stock price for Exelixis (NASDAQ: EXEL) is $21.96 last updated Today at July 3, 2024 at 1:00 PM EDT.
Does Exelixis (EXEL) pay a dividend?
There are no upcoming dividends for Exelixis.
When is Exelixis (NASDAQ:EXEL) reporting earnings?
Exelixis’s Q2 earnings are confirmed for Tuesday, July 30, 2024.
Is Exelixis (EXEL) going to split?
There is no upcoming split for Exelixis.
What sector and industry does Exelixis (EXEL) operate in?
Exelixis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.